Systematic review and meta-analysis of liver resection for metastatic melanoma
Open Access
- 17 June 2013
- journal article
- review article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 100 (9) , 1138-1147
Abstract
Background The multidisciplinary management of metastatic melanoma now occasionally includes major hepatic resection. The objective of this work was to conduct a systematic review of the literature on liver resection for metastatic melanoma. Methods MEDLINE, Embase, the Cochrane Library and Scopus were searched (1990 to December 2012). Studies with at least ten patients undergoing liver resection for metastatic melanoma were included. Data on the outcomes of overall survival (OS) and/or disease‐free survival (DFS) were abstracted and synthesized. Hazard ratios (HRs) were derived from survival curves and subjected to meta‐analysis using random‐effects models. Results Twenty‐two studies involving 579 patients (13 per cent weighted resection rate) who underwent liver resection were included. Study quality was poor to moderate. Median follow‐up ranged from 9 to 59 months. Median DFS ranged from 8 to 23 months, and median OS ranged from 14 to 41 months (R0, 22–66 months, R2, 10–16 months; R0 versus R1/R2: HR 0.52, 95 per cent confidence interval (c.i.) 0.37 to 0.73). The OS rate was 56–100 per cent at 1 year, 34–53 per cent at 3 years and 11–36 per cent at 5 years. Median OS with non‐operative management ranged from 4 to 12 months. Comparison of OS with resection and non‐operative management favoured resection (HR 0.32, 95 per cent c.i. 0.22 to 0.46). Conclusion Radical resection of liver metastases from melanoma appears to improve overall survival compared with non‐operative management or incomplete resection, but this observation requires future confirmation as selection bias may have confounded the results.Keywords
This publication has 42 references indexed in Scilit:
- MRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patientsBritish Journal of Ophthalmology, 2012
- The nuts and bolts of PROSPERO: an international prospective register of systematic reviewsSystematic Reviews, 2012
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E MutationNew England Journal of Medicine, 2011
- KIT as a Therapeutic Target in Metastatic MelanomaJAMA, 2011
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010
- Surgical management of liver metastases from uveal melanoma: 16 years' experience at the Institut CurieEuropean Journal of Surgical Oncology, 2009
- Long-term survival of uveal melanoma patients after surgery for liver metastasesBritish Journal of Ophthalmology, 2009
- Practical methods for incorporating summary time-to-event data into meta-analysisTrials, 2007
- Variates of Survival in Metastatic Uveal MelanomaJournal of Clinical Oncology, 2005
- Does Complete Resection of Melanoma Metastatic to Solid Intra-Abdominal Organs Improve Survival?Annals of Surgical Oncology, 2001